BSEBoard Meeting3d ago · 4 Nov 2026, 02:27 pm
Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve to consider and approve, inter alia, Unaudited Financial Result (Standalone) for the Second quarter and half year ended on September 30th, 2026
Kimia Biosciences Ltd · 530313
✦ AI SummaryResults
Kimia Biosciences Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/11/2026 to consider and approve the Unaudited Financial Results (Standalone) for the Second quarter and Half year ended on September 30th, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Kimia Biosciences Ltd - 530313 - Board Meeting Intimation for Board Meeting Intimation Under Regulation 29 Of SEBI (LODR) Regulations, 2015 -Intimation Of Meeting Of Board Of Directors.
Attachments (1)
📄pdf
Download →
19ac96a5-0d9c-499e-b514-e53d24feb64f.pdf
View document text
To Date: 04/11/2026
Department of Corporate Affairs-
Listing, BSE Limited,
Phiroz Jee Jeebhoy Towers, Dalal
Street, Fort Mumbai-400001.
Scrip Code: 530313 [KIMIABL]
Sub: Regulation 29 of SEBI (LODR) Regulations, 2015 –Intimation of Meeting
of Board of Directors.
Dear Sir/Madam
Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that
the meeting of Board of Directors of the Company is scheduled to be held on Friday,
November 13, 2026, inter alia, to consider & approve the Un-Audited Financial Results
(Standalone) for the Second quarter and Half year ended on September 30th, 2026.
Further, In terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and
Company’s Code of Internal Procedures and Conduct for Regulating, Monitoring and
Reporting of Trading by Insiders, the Trading Window for dealing in the Equity Shares
of the Company by Designated Persons (and their immediate relatives) has already been
closed w.e.f. 1st of October, 2026 up to the completion of 48 hours after the declaration
of unaudited Financial Results for the Second quarter and half year ended on 30th
September 2026 to the Stock Exchange.
This is for your information and records.
Thanking you,
For Kimia Biosciences Limited
Abhishek Kumar Pandey
Company Secretary & Compliance Officer
Membership No.: F12457
Place- Delhi
KIMIA BIOSCIENCES LIMITED
Regd. Office/Works
Corporate Office
Village Bhondsi, Damdama Lake Road,
974,9" Floor, Aggarwal Millennium Tower-II
Gurugram, Haryana-122102
Netaji Subhash Place, Pitampura, New Delhi-110034, INDIA
Tel.: +91 9654746544, 9654206544
Tel.: +91 11 47063600, 470630601
compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120